Company registration number 15781760 (England and Wales)
SPECIALIST PRESCRIBING GROUP LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2025
PAGES FOR FILING WITH REGISTRAR
SPECIALIST PRESCRIBING GROUP LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2
SPECIALIST PRESCRIBING GROUP LTD
BALANCE SHEET
AS AT
30 JUNE 2025
30 June 2025
- 1 -
2025
Notes
£
£
Current assets
Cash at bank and in hand
18,854
Creditors: amounts falling due within one year
3
(20,380)
Net current liabilities
(1,526)
Capital and reserves
Called up share capital
100
Profit and loss reserves
(1,626)
Total equity
(1,526)

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial period ended 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 8 April 2026 and are signed on its behalf by:
Mr D C Hume
Director
Company registration number 15781760 (England and Wales)
SPECIALIST PRESCRIBING GROUP LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2025
- 2 -
1
Accounting policies
Company information

Specialist Prescribing Group Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Amelia House, Crescent Road, Worthing, West Sussex, BN11 1RL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

A true t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was 4.

3
Creditors: amounts falling due within one year
2025
£
Other creditors
20,380
2025-06-30 2024-06-16 false false false 08 April 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Mr J L Caines-Gooby Ms A C Emkes Mr Daniel Hume Ms L E Woods 4 15781760 2024-06-16 2025-06-30 15781760 2025-06-30 15781760 core:CurrentFinancialInstruments core:WithinOneYear 2025-06-30 15781760 core:ShareCapital 2025-06-30 15781760 core:RetainedEarningsAccumulatedLosses 2025-06-30 15781760 bus:Director3 2024-06-16 2025-06-30 15781760 core:CurrentFinancialInstruments 2025-06-30 15781760 bus:PrivateLimitedCompanyLtd 2024-06-16 2025-06-30 15781760 bus:SmallCompaniesRegimeForAccounts 2024-06-16 2025-06-30 15781760 bus:FRS102 2024-06-16 2025-06-30 15781760 bus:AuditExempt-NoAccountantsReport 2024-06-16 2025-06-30 15781760 bus:Director1 2024-06-16 2025-06-30 15781760 bus:Director2 2024-06-16 2025-06-30 15781760 bus:Director4 2024-06-16 2025-06-30 15781760 bus:FullAccounts 2024-06-16 2025-06-30 xbrli:pure xbrli:shares iso4217:GBP